AT1 4.55% 2.1¢ atomo diagnostics limited

Ann: Atomo & Access Bio enter North American COVID-19 partnership, page-126

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 185 Posts.
    lightbulb Created with Sketch. 34
    This is very interesting. Just found this video regarding Access bios FDA approvals. I believe they have already submitted the FDA eua dossier for Point of care (POC) testing (using Atomo's technology) and expect approval in 4 to 6 weeks. There is also a discussion around the use of this POC test and its distribution and testing at all the major US pharmacies (CVS, Walgreens etc). I think this is going to be huge!

    https://www.bloomberg.com/news/videos/2020-08-12/intrivo-diagnostics-gets-fda-approval-for-covid-tests-video
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
-0.001(4.55%)
Mkt cap ! $13.42M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $8.115K 394.5K

Buyers (Bids)

No. Vol. Price($)
10 650696 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 5440 1
View Market Depth
Last trade - 14.22pm 15/11/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.